Free Trial
→ Trump’s treachery (From Porter & Company) (Ad) Buy OCS Stock  Free OCS Stock Alerts

Oculis (OCS) Financials

Oculis logo
$19.42 -0.09 (-0.44%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Oculis

Annual Income Statements for Oculis

This table shows Oculis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Income / (Loss) Attributable to Common Shareholders		 -95 -106 -42 -20 -17
Consolidated Net Income / (Loss)		 -95 -106 -42 -20 -17
Net Income / (Loss) Continuing Operations		 -95 -106 -42 -20 -17
Total Pre-Tax Income 		-95 -106 -42 -20 -17
Total Operating Income		 -78 -95 -35 -14 -14
Total Gross Profit		 3.15 1.70 0.99 1.07 1.32
Total Revenue		 3.15 1.70 0.99 1.07 1.32
Operating Revenue		 3.15 1.70 0.99 1.07 1.32
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 81 97 36 16 15
Selling, General & Admin Expense		 24 21 12 5.06 4.51
Research & Development Expense		 57 35 24 10 11
Other Operating Expenses / (Income)		 0.00 41 - 0.00 -
Total Other Income / (Expense), net		 -16 -11 -6.78 -5.81 -2.97
Interest Expense		 0.70 1.56 6.97 5.60 2.97
Other Income / (Expense), net		 -16 -9.63 - -0.21 -
Income Tax Expense		 -0.18 0.13 0.06 0.03 0.09
Weighted Average Basic Shares Outstanding		 47.68M 40.90M 37.14M - -
Weighted Average Diluted Shares Outstanding		 47.68M 40.90M 37.14M - -
Weighted Average Basic & Diluted Shares Outstanding		 47.68M 40.90M 37.14M - -

Quarterly Income Statements for Oculis

No quarterly income statements for Oculis are available.

Annual Cash Flow Statements for Oculis

This table details how cash moves in and out of Oculis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Net Change in Cash & Equivalents		 57 154 -29 45 -8.12
Net Cash From Operating Activities		 -2.59 0.14 -27 -15 -14
Net Cash From Continuing Operating Activities		 -2.59 0.14 -32 -16 -14
Net Income / (Loss) Continuing Operations		 0.00 0.00 -42 -20 -17
Depreciation Expense		 0.45 0.34 0.32 0.10 0.12
Non-Cash Adjustments To Reconcile Net Income		 -3.04 -0.20 7.82 4.96 3.29
Net Cash From Investing Activities		 0.00 0.00 -3.84 -0.03 -0.02
Net Cash From Continuing Investing Activities		 0.00 0.00 -3.84 -0.03 -0.02
Net Cash From Financing Activities		 60 154 1.85 60 5.49
Net Cash From Continuing Financing Activities		 60 154 2.15 61 5.56
Cash Interest Received		 1.63 1.47 - - -

Quarterly Cash Flow Statements for Oculis

No quarterly cash flow statements for Oculis are available.

Annual Balance Sheets for Oculis

This table presents Oculis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Total Assets		 133 136 40 63
Total Current Assets		 116 120 26 52
Cash & Equivalents		 31 46 21 51
Other Current Assets		 78 63 3.20 1.03
Plant, Property, & Equipment, net		 0.42 0.34 0.39 0.47
Plant, Property & Equipment, gross		 0.42 0.34 0.39 0.47
Total Noncurrent Assets		 17 16 14 11
Intangible Assets		 15 15 13 9.54
Other Noncurrent Operating Assets		 1.96 1.00 0.90 0.93
Total Liabilities & Shareholders' Equity		 133 136 40 63
Total Liabilities		 52 25 146 130
Total Current Liabilities		 49 23 13 4.44
Accounts Payable		 6.47 9.04 4.18 0.90
Accrued Expenses		 20 7.08 8.67 3.33
Other Current Liabilities		 0.35 0.21 0.15 0.21
Total Noncurrent Liabilities		 3.02 1.83 133 126
Capital Lease Obligations		 0.95 0.51 0.53 0.63
Noncurrent Employee Benefit Liabilities		 2.06 0.87 - -
Other Noncurrent Operating Liabilities		 0.00 0.45 - 124
Total Equity & Noncontrolling Interests		 81 112 -106 -67
Total Preferred & Common Equity		 83 113 -106 -66
Preferred Stock		 380 343 12 11
Total Common Equity		 -297 -230 -117 -77
Common Stock		 0.49 0.44 0.04 0.37
Retained Earnings		 -315 -238 -120 -79
Treasury Stock		 -0.01 0.00 -0.00 -0.11
Other Equity Adjustments		 17 7.20 2.67 1.82

Quarterly Balance Sheets for Oculis

No quarterly balance sheets for Oculis are available.

Annual Metrics And Ratios for Oculis

This table displays calculated financial ratios and metrics derived from Oculis' official financial filings.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Growth Metrics		 - - - - -
Revenue Growth		 85.12% 72.27% -7.99% -18.53% 0.00%
EBITDA Growth		 10.56% -201.54% -138.41% -6.93% 0.00%
EBIT Growth		 10.43% -199.73% -139.06% -6.71% 0.00%
NOPAT Growth		 17.87% -172.24% -142.55% -5.18% 0.00%
Net Income Growth		 10.47% -152.30% -106.45% -20.78% 0.00%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -1,978.55% 100.51% -79.50% -11.29% 0.00%
Free Cash Flow Firm Growth		 51.92% 15.13% -236.95% 0.00% 0.00%
Invested Capital Growth		 7.56% 1,212.62% 104.03% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -2,974.49% -6,156.47% -3,517.22% -1,357.39% -1,034.22%
Operating Margin		 -2,489.00% -5,610.08% -3,550.00% -1,346.69% -1,043.14%
EBIT Margin		 -2,988.72% -6,176.56% -3,550.00% -1,366.36% -1,043.14%
Profit (Net Income) Margin		 -3,005.50% -6,214.28% -4,243.20% -1,891.13% -1,275.56%
Tax Burden Percent		 99.81% 100.12% 100.14% 100.15% 100.56%
Interest Burden Percent		 100.75% 100.49% 119.36% 138.20% 121.60%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -85.67% -201.18% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 37.75% -328.89% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -12.64% -3,658.18% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -98.31% -3,859.37% 48.50% 30.44% 0.00%
Cash Return on Invested Capital (CROIC)		 -92.96% -372.87% -3,103.03% 0.00% 0.00%
Operating Return on Assets (OROA)		 -69.99% -119.23% -67.66% -23.09% 0.00%
Return on Assets (ROA)		 -70.39% -119.95% -80.87% -31.96% 0.00%
Return on Common Equity (ROCE)		 269.26% 244,900.45% 54.58% 35.14% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -113.44% -93.67% 39.60% 30.95% 0.00%
Net Operating Profit after Tax (NOPAT)		 -55 -67 -25 -10 -9.61
NOPAT Margin		 -1,742.30% -3,927.06% -2,485.00% -942.68% -730.20%
Net Nonoperating Expense Percent (NNEP)		 -123.42% 127.71% 57.07% -40.75% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -66.97% -59.60% -90.84% - -
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 764.09% 1,223.72% 1,213.16% 471.36% 342.37%
R&D to Revenue		 1,824.91% 2,046.68% 2,436.84% 975.33% 800.77%
Operating Expenses to Revenue		 2,589.00% 5,710.08% 3,650.00% 1,446.69% 1,143.14%
Earnings before Interest and Taxes (EBIT)		 -94 -105 -35 -15 -14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -94 -105 -35 -15 -14
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 88.58 108.32 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 9.49 7.81 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 200.03 283.45 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 3,491.81 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.01 0.00 -1.25 -0.01 0.00
Long-Term Debt to Equity		 0.01 0.00 -1.25 -0.01 0.00
Financial Leverage		 -0.33 11.12 -0.35 0.75 0.00
Leverage Ratio		 1.40 32.17 -0.60 -0.95 0.00
Compound Leverage Factor		 1.41 32.33 -0.72 -1.32 0.00
Debt to Total Capital		 1.17% 0.46% 492.77% -0.96% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 1.17% 0.46% 492.77% -0.96% 0.00%
Preferred Equity to Total Capital		 464.59% 306.04% 43.06% -17.28% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -362.74% -205.36% -434.76% 116.57% 0.00%
Debt to EBITDA		 -0.01 0.00 -3.83 -0.04 0.00
Net Debt to EBITDA		 0.32 0.43 -3.22 3.44 0.00
Long-Term Debt to EBITDA		 -0.01 0.00 -3.83 -0.04 0.00
Debt to NOPAT		 -0.02 -0.01 -5.42 -0.06 0.00
Net Debt to NOPAT		 0.54 0.68 -4.55 4.95 0.00
Long-Term Debt to NOPAT		 -0.02 -0.01 -5.42 -0.06 0.00
Altman Z-Score		 -1.80 0.38 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 373.89% 6,445.61% -12.53% -15.46% 0.00%
Liquidity Ratios		 - - - - -
Current Ratio		 2.37 5.29 1.97 11.81 0.00
Quick Ratio		 0.63 2.01 1.65 11.39 0.00
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 -60 -124 -146 106 0.00
Operating Cash Flow to CapEx		 0.00% 0.00% -706.71% -49,375.77% -63,309.86%
Free Cash Flow to Firm to Interest Expense		 -84.44 -79.09 -20.91 19.02 0.00
Operating Cash Flow to Interest Expense		 -3.68 0.09 -3.89 -2.70 -4.58
Operating Cash Flow Less CapEx to Interest Expense		 -3.68 0.09 -4.44 -2.71 -4.58
Efficiency Ratios		 - - - - -
Asset Turnover		 0.02 0.02 0.02 0.02 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 8.20 4.61 2.28 2.28 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - -
Invested Capital		 66 62 4.70 -117 0.00
Invested Capital Turnover		 0.05 0.05 -0.02 -0.02 0.00
Increase / (Decrease) in Invested Capital		 4.66 57 121 -117 0.00
Enterprise Value (EV)		 630 482 0.00 0.00 0.00
Market Capitalization		 279 184 0.00 0.00 0.00
Book Value per Share		 ($7.26) ($6.19) ($3.16) $0.00 $0.00
Tangible Book Value per Share		 ($7.62) ($6.59) ($3.52) $0.00 $0.00
Total Capital		 82 112 27 -66 0.00
Total Debt		 0.95 0.51 133 0.63 0.00
Total Long-Term Debt		 0.95 0.51 133 0.63 0.00
Net Debt		 -30 -45 112 -50 0.00
Capital Expenditures (CapEx)		 0.00 0.00 3.84 0.03 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 36 52 -8.82 -2.58 0.00
Debt-free Net Working Capital (DFNWC)		 67 97 13 48 0.00
Net Working Capital (NWC)		 67 97 13 48 0.00
Net Nonoperating Expense (NNE)		 40 39 17 10 7.18
Net Nonoperating Obligations (NNO)		 -15 -50 111 -50 0.00
Total Depreciation and Amortization (D&A)		 0.45 0.34 0.32 0.10 0.12
Debt-free, Cash-free Net Working Capital to Revenue		 1,154.66% 3,051.09% -893.53% -240.37% 0.00%
Debt-free Net Working Capital to Revenue		 2,125.51% 5,733.17% 1,275.99% 4,476.96% 0.00%
Net Working Capital to Revenue		 2,125.51% 5,733.17% 1,275.99% 4,476.96% 0.00%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 47.68M 40.90M 37.14M 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 47.68M 40.90M 37.14M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 47.68M 40.90M 37.14M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -55 -67 -25 -10 -9.61
Normalized NOPAT Margin		 -1,742.30% -3,927.06% -2,485.00% -942.68% -730.20%
Pre Tax Income Margin		 -3,011.11% -6,206.79% -4,237.17% -1,888.28% -1,268.44%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 -133.49 -67.12 -5.03 -2.62 -4.63
NOPAT to Interest Expense		 -77.82 -42.68 -3.52 -1.81 -3.24
EBIT Less CapEx to Interest Expense		 -133.49 -67.12 -5.58 -2.62 -4.64
NOPAT Less CapEx to Interest Expense		 -77.82 -42.68 -4.07 -1.81 -3.25
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Oculis

No quarterly metrics and ratios for Oculis are available.

Frequently Asked Questions About Oculis' Financials

When does Oculis's financial year end?

According to the most recent income statement we have on file, Oculis' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Oculis' net income changed over the last 4 years?

Oculis' net income appears to be on an upward trend, with a most recent value of -$94.59 million in 2024, rising from -$16.79 million in 2020. The previous period was -$105.65 million in 2023. Find out what analysts predict for Oculis in the coming months.

What is Oculis's operating income?
Oculis's total operating income in 2024 was -$78.34 million, based on the following breakdown:
  • Total Gross Profit: $3.15 million
  • Total Operating Expenses: $81.48 million
How has Oculis revenue changed over the last 4 years?

Over the last 4 years, Oculis' total revenue changed from $1.32 million in 2020 to $3.15 million in 2024, a change of 139.1%.

How much debt does Oculis have?

Oculis' total liabilities were at $51.80 million at the end of 2024, a 111.1% increase from 2023, and a 60.2% decrease since 2021.

How much cash does Oculis have?

In the past 3 years, Oculis' cash and equivalents has ranged from $21.41 million in 2022 to $50.60 million in 2021, and is currently $30.56 million as of their latest financial filing in 2024.

How has Oculis' book value per share changed over the last 4 years?

Over the last 4 years, Oculis' book value per share changed from 0.00 in 2020 to -7.26 in 2024, a change of -726.1%.


Related Companies

This page (NASDAQ:OCS) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...
Crypto 101 Media | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...
Golden Portfolio | Sponsored
Urgent: Make this trade before you hit your pillow tonight…
Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...
Timothy Sykes | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
HISTORIC Gold Move Sends Flashing Red Signal To 401K Savers
Historically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...
Colonial Metals | Sponsored
The one deadline Elon can't afford to miss...
For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...
Brownstone Research | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored